Marinus Pharmaceuticals (MRNS) Competitor Comparison
We are evaluating the key criteria listed to compare Marinus Pharmaceuticals (MRNS) against its competitors in the Biotechnology industry.
Market Capitalization
165 / 368Gross Profits
202 / 278Total Revenue
143 / 300EBITDA
224 / 337Free Cashflow
259 / 352Quick Ratio
159 / 357Earnings per Share
238 / 359Dividend yield
0 / 6Total Cash
170 / 358Performance 3 years
262 / 368Performance 5 years
210 / 368Performance 10 years
269 / 368Linearity 3 years
149 / 368Linearity 5 years
67 / 368Linearity 10 years
177 / 368Total Rank
191 / 368Dividend Rank
197 / 368Valuation Rank
149 / 368Piotroski Rank
85 / 368Muliplier Rank
151 / 368Dividend yield - MRNS ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.